{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:56:46Z","timestamp":1790117806814,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Breast cancer-related lymphedema (BCRL) represents a significant concern for patients following breast cancer treatment, and assessment for BCRL represents a key component of survivorship efforts. Growing data has demonstrated the benefits of early detection and treatment of BCRL. Traditional diagnostic modalities are less able to detect reversible subclinical BCRL while newer techniques such as bioimpedance spectroscopy (BIS) have shown the ability to detect subclinical BCRL, allowing for early intervention and low rates of chronic BCRL with level I evidence. We present updated clinical practice guidelines for BIS utilization to assess for BCRL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p>Review of the literature identified a randomized controlled trial and other published data which form the basis for the recommendations made. The final results of the PREVENT trial, with 3-year follow-up, demonstrated an absolute reduction of 11.3% and relative reduction of 59% in chronic BCRL (through utilization of compression garment therapy) with BIS as compared to tape measurement. This is in keeping with real-world data demonstrating the effectiveness of BIS in a prospective surveillance model. For optimal outcomes patients should receive an initial pre-treatment measurement and subsequently be\u00a0followed at a minimum quarterly for first 3\u00a0years then biannually for years 4\u20135, then annually as appropriate, consistent with previous guidelines; the target for intervention has been changed from a change in L-Dex\u00a0of 10 to 6.5. The lack of pre-operative measure does not preclude inclusion in the prospective surveillance model of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The updated clinical practice guidelines present a standardized approach for a prospective model of care using BIS for BCRL assessment and supported by evidence from a randomized controlled trial as well as real-world data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-022-06850-7","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T12:02:33Z","timestamp":1671883353000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-5554","authenticated-orcid":false,"given":"Chirag","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham S.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstyn","family":"Brownson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Dupree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"issue":"4","key":"6850_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.ijrobp.2011.05.043","volume":"81","author":"C Shah","year":"2011","unstructured":"Shah C, Vicini FA (2011) Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 81(4):907\u2013914","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6850_CR2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3517","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2008.18.3517","journal-title":"J Clin Oncol"},{"issue":"4","key":"6850_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/lrb.2014.0030","volume":"12","author":"MJ Lee","year":"2014","unstructured":"Lee MJ, Beith J, Ward L, Kilbreath S (2014) Lymphedema following taxane-based chemotherapy in women with early breast cancer. Lymphat Res Biol 12(4):282\u2013288","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"6850_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-014-3137-x","volume":"148","author":"S-Y Jung","year":"2014","unstructured":"Jung S-Y, Shin KH, Kim M et al (2014) Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients. Breast Cancer Res Treat 148(1):91\u201398","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6850_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/caac.21319","volume":"66","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43\u201373","journal-title":"CA Cancer J Clin"},{"key":"6850_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ptj\/pzx050","volume":"97","author":"K Levenhagen","year":"2017","unstructured":"Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L (2017) Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the oncology section of the American Physical Therapy Association. Phys Ther 97:1\u201317","journal-title":"Phys Ther"},{"key":"6850_CR7","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Breast Cancer V.2.2022. 2022."},{"key":"6850_CR8","unstructured":"NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Survivorship V.3.2021. 2021."},{"key":"6850_CR9","unstructured":"British Lymphology Society, Lymph Facts - What information, advice and support should be provided for those at risk of lymphoedema? Available at: https:\/\/www.thebls.com\/documents-library. Accessed 2 Aug 2022."},{"key":"6850_CR10","unstructured":"Australasian Lymphology Association, Position Paper \u2013 Early detection of breast cancer-related lymphoedema Available at: https:\/\/www.lymphoedema.org.au\/about-lymphoedema\/position-statements\/. Accessed 2 Aug 2022."},{"key":"6850_CR11","doi-asserted-by":"publisher","DOI":"10.4172\/2327-4360.1000102","author":"C Shah","year":"2013","unstructured":"Shah C, Badiyan S, Khwaja S et al (2013) Breast cancer related lymphedema: a review of recent developments. Androl Gynecol. https:\/\/doi.org\/10.4172\/2327-4360.1000102","journal-title":"Androl Gynecol"},{"issue":"1","key":"6850_CR12","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, Chapman M, Hirst C et al (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34(1):2\u201311","journal-title":"Lymphology"},{"issue":"12","key":"6850_CR13","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"112","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809\u20132819","journal-title":"Cancer"},{"issue":"24","key":"6850_CR14","first-page":"1s","volume":"71","author":"NL Stout","year":"2011","unstructured":"Stout NL, Pfalzer L, Levy E, McGarvey C, Gerber L, Springer B, Soballe P (2011) Five year preliminary outcomes of a prospective surveillance model to reduce upper extremity morbidity related to breast cancer treatment. Can Res 71(24):1s\u2013653s","journal-title":"Can Res"},{"issue":"4","key":"6850_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lrb.2014.0035","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Ozmen T, McGuire KP et al (2014) The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol 12(4):289\u2013294","journal-title":"Lymphat Res Biol"},{"issue":"6","key":"6850_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cncr.31873","volume":"125","author":"LA Koelmeyer","year":"2018","unstructured":"Koelmeyer LA, Borotkanics RJ, Alcorso J et al (2018) Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer 125(6):854\u2013862","journal-title":"Cancer"},{"key":"6850_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fonc.2018.00197","volume":"8","author":"PW Whitworth","year":"2018","unstructured":"Whitworth PW, Shah C, Vicini F, Cooper A (2018) Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy. Front Oncol 8:197","journal-title":"Front Oncol"},{"issue":"6","key":"6850_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/lrb.2017.0078","volume":"16","author":"F Vicini","year":"2018","unstructured":"Vicini F, Shah C, Whitworth P, Walker M, Shi J (2018) Correlation of bioimpedance spectroscopy with risk factors for the development of breast cancer-related lymphedema. Lymphat Res Biol 16(6):533\u2013537","journal-title":"Lymphat Res Biol"},{"issue":"4","key":"6850_CR19","first-page":"184","volume":"46","author":"C Shah","year":"2013","unstructured":"Shah C, Vicini F, Beitsch P et al (2013) The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. Lymphology 46(4):184\u2013192","journal-title":"Lymphology"},{"issue":"1","key":"6850_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/lrb.2006.4.51","volume":"4","author":"LC Ward","year":"2006","unstructured":"Ward LC (2006) Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 4(1):51\u201356","journal-title":"Lymphat Res Biol"},{"issue":"11","key":"6850_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1365-2362.1992.tb01440.x","volume":"22","author":"LC Ward","year":"1992","unstructured":"Ward LC, Bunce IH, Cornish BH, Mirolo BR, Thomas BJ, Jones LC (1992) Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients. Eur J Clin Invest 22(11):751\u2013754","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"6850_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10549-017-4451-x","volume":"166","author":"DI Kaufman","year":"2017","unstructured":"Kaufman DI, Shah C, Vicini FA, Rizzi M (2017) Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema. Breast Cancer Res Treat 166(3):809\u2013815","journal-title":"Breast Cancer Res Treat"},{"key":"6850_CR23","unstructured":"Hypofractionated radiation therapy after mastectomy in preventing recurrence in patients with Stage IIA-IIA Breast Cancer. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03414970. Accessed 2 Aug 2022."},{"issue":"6","key":"6850_CR24","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/tbj.12647","volume":"22","author":"C Shah","year":"2016","unstructured":"Shah C, Vicini FA, Arthur D (2016) Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines. Breast journal 22(6):645\u2013650","journal-title":"Breast journal"},{"issue":"10","key":"6850_CR25","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1245\/s10434-019-07344-5","volume":"26","author":"SH Ridner","year":"2019","unstructured":"Ridner SH, Dietrich MS, Cowher MS et al (2019) A Randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26(10):3250\u20133259","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6850_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/lrb.2010.0020","volume":"9","author":"R Gaw","year":"2011","unstructured":"Gaw R, Box R, Cornish B (2011) Bioimpedance in the assessment of unilateral lymphedema of a limb: the optimal frequency. Lymphat Res Biol 9(2):93\u201399","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"6850_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2010.0014","volume":"9","author":"L Ward","year":"2011","unstructured":"Ward L, Dylke E, Czerniec S, Isenring E, Kilbreath S (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9(1):47\u201351","journal-title":"Lymphat Res Biol"},{"issue":"5","key":"6850_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/lrb.2017.0070","volume":"16","author":"SH Ridner","year":"2018","unstructured":"Ridner SH, Dietrich MS, Spotanski K et al (2018) A prospective study of L-Dex values in breast cancer patients pretreatment and through 12 months postoperatively. Lymphat Res Biol 16(5):435\u2013441","journal-title":"Lymphat Res Biol"},{"issue":"3","key":"6850_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/lrb.2015.0019","volume":"13","author":"T Lahtinen","year":"2015","unstructured":"Lahtinen T, Seppala J, Viren T, Johansson K (2015) Experimental and analytical comparisons of tissue dielectric constant (TDC) and bioimpedance spectroscopy (BIS) in assessment of early arm lymphedema in breast cancer patients after axillary surgery and radiotherapy. Lymphat Res Biol 13(3):176\u2013185","journal-title":"Lymphat Res Biol"},{"issue":"12","key":"6850_CR30","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/0284186X.2016.1191668","volume":"55","author":"ES Dylke","year":"2016","unstructured":"Dylke ES, Schembri GP, Bailey DL et al (2016) Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol 55(12):1477\u20131483","journal-title":"Acta Oncol"},{"issue":"2","key":"6850_CR31","first-page":"85","volume":"46","author":"MR Fu","year":"2013","unstructured":"Fu MR, Cleland CM, Guth AA et al (2013) L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology 46(2):85\u201396","journal-title":"Lymphology"},{"key":"6850_CR32","doi-asserted-by":"publisher","first-page":"b5396","DOI":"10.1136\/bmj.b5396","volume":"340","author":"M Torres Lacomba","year":"2010","unstructured":"Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A et al (2010) Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 340:b5396","journal-title":"BMJ"},{"issue":"1","key":"6850_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1016591121762","volume":"75","author":"RC Box","year":"2002","unstructured":"Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat 75(1):51\u201364","journal-title":"Breast Cancer Res Treat"},{"key":"6850_CR34","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2021.0084","author":"SH Ridner","year":"2022","unstructured":"Ridner SH, Dietrich MS, Boyages J et al (2022) A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymph Res Biol. https:\/\/doi.org\/10.1089\/lrb.2021.0084","journal-title":"Lymph Res Biol"},{"issue":"10","key":"6850_CR35","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1245\/s10434-018-6601-8","volume":"25","author":"LJ Kilgore","year":"2018","unstructured":"Kilgore LJ, Korentager SS, Hangge AN et al (2018) Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol 25(10):2948\u20132952","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"6850_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00520-020-05597-5","volume":"29","author":"L Koelmeyer","year":"2021","unstructured":"Koelmeyer L, Gaitatzis K, Ridner SH et al (2021) Implementing a prospective surveillance and early intervention model of care for breast cancer\u2013related lymphedema into clinical practice: application of the RE-AIM framework. Supportive Care Cancer 29(2):1081\u20131089","journal-title":"Supportive Care Cancer"},{"issue":"1","key":"6850_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20001","volume":"59","author":"BD Lawenda","year":"2009","unstructured":"Lawenda BD, Mondry TE, Johnstone PA (2009) Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin 59(1):8\u201324","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6850_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/lrb.2019.0067","volume":"18","author":"LA Koelmeyer","year":"2020","unstructured":"Koelmeyer LA, Ward LC, Dean C, Boyages J (2020) Body positional effects on bioimpedance spectroscopy measurements for lymphedema assessment of the arm. Lymphat Res Biol 18(5):464\u2013473","journal-title":"Lymphat Res Biol"},{"key":"6850_CR39","unstructured":"FDA. K180126 - SOZO - L-Dex Monitor, Extracellular Fluid, Lymphedema, Extremity. Silver Spring MD: US Food and Drug Administration; 2008."},{"key":"6850_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.08.036","author":"SGR McDuff","year":"2018","unstructured":"McDuff SGR, Mina AI, Brunelle CL et al (2018) Timing of lymphedema following treatment for breast cancer: when are patients most at-risk? Int J Radiat Oncol Biol Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6850_CR41","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1002\/cam4.3188","volume":"9","author":"SH Ridner","year":"2020","unstructured":"Ridner SH, Shah C, Boyages J et al (2020) L-Dex, arm volume, and symptom trajectories 24 months after breast cancer surgery. Cancer Med 9:5164\u20135173","journal-title":"Cancer Med"},{"issue":"3","key":"6850_CR42","first-page":"242","volume":"26","author":"SA McLaughlin","year":"2012","unstructured":"McLaughlin SA (2012) Lymphedema: separating fact from fiction. Oncology 26(3):242\u2013249","journal-title":"Oncology"},{"issue":"9","key":"6850_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1200\/JCO.21.01681","volume":"40","author":"BS Rafn","year":"2002","unstructured":"Rafn BS, Christensen J, Larsen A et al (2002) Prospective surveillance for breast cancer- related arm lymphedema: a systematic review and meta-analysis. J Clin Oncol 40(9):1009\u20131026","journal-title":"J Clin Oncol"},{"key":"6850_CR44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02567","author":"VS Paramandandam","year":"2022","unstructured":"Paramandandam VS, Dylke E, Clark GM et al (2022) Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.21.02567","journal-title":"J Clin Oncol"},{"issue":"1","key":"6850_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2015.06.015","volume":"211","author":"MN Basta","year":"2016","unstructured":"Basta MN, Fox JP, Kanchwala SK et al (2016) Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 211(1):133\u2013141","journal-title":"Am J Surg"},{"issue":"1","key":"6850_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2522\/ptj.20100167","volume":"92","author":"NL Stout","year":"2012","unstructured":"Stout NL, Pfalzer LA, Springer B et al (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92(1):152\u2013163","journal-title":"Phys Ther"},{"issue":"6","key":"6850_CR47","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/tbj.13618","volume":"25","author":"C Shah","year":"2019","unstructured":"Shah C (2019) Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: an ounce of prevention. Breast J 25(6):1323\u20131325","journal-title":"Breast J"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06850-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:35:24Z","timestamp":1674779724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6850"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06850-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chirag Shah- Scientific Consultant ImpediMed, Consultant PreludeX, Consultant Evicore, Consultant Videra Surgical. Frank Vicini- CMO ImpediMed. Stephanie Valente- Oncology Advisory Board\/Consultant for ImpediMed, AxoGen, Merit and Pacira. Pat Whitworth- Partner TME LLC, Consultant Impedimed. Graham Schwarz- Consultant Impedimed, Quest Medical Imaging. Megan Kruse declares that she has no conflicts of interest. Manpreet Kohli- Oncology Advisory Board, Impedimed. Kirstyn Brownson- Oncology Advisory Board, Impedimed. Laura Lawson- Oncology Advisory Board, Impedimed. Beth Dupree declares that she has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}